Olive Tang, MD/PhD Student Johns Hopkins School of Medicine

26 Mar Biomarker hsTroponin Predictive of Mortality Risk in Older Diabetics

Posted at 16:26h in Author Interviews, Biomarkers, Diabetes, Diabetes Care, Johns Hopkins by

MedicalResearch.com Interview with:

Olive Tang, MD/PhD Student Johns Hopkins School of Medicine

Olive Tang

Olive Tang, MD/PhD Student
Johns Hopkins School of Medicine

 

Elizabeth Selvin, PhD, MPH Professor of Epidemiology & Medicine Director, Cardiovascular and Clinical Epidemiology  Department of Epidemiology Welch Center for Prevention, Epidemiology and Clinical Research and the Johns Hopkins Bloomberg School of Public Health

Dr. Selvin

Elizabeth Selvin, PhD, MPH
Professor of Epidemiology & Medicine
Director, Cardiovascular and Clinical Epidemiology
Department of Epidemiology
Welch Center for Prevention, Epidemiology and Clinical Research and the
Johns Hopkins Bloomberg School of Public Health


MedicalResearch.com: What is the background for this study?

Response: The best approach to diabetes management in older adults is unclear. A new blood test called high-sensitivity troponin can detect damage to the heart, even in people without any signs or symptoms of heart disease.

MedicalResearch.com: What are the main findings?

Response: We found that high-sensitivity troponin can predict short-term risk of death in older adults with diabetes. This was true even in people with other co-existing conditions.

MedicalResearch.com: What should readers take away from your report?

Response: High-sensitivity troponin may be informative to guide care and decisions regarding medications and treatment targets in older adults with diabetes.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: There is growing evidence supporting the use of high-sensitivity troponin to monitor risk of heart disease or death. It may be time to explore how to integrate the use of high sensitivity troponin into clinical practice to help monitor risk and improve treatment in adults with diabetes and other conditions.

No disclosures.

Citation:

Tang O, Daya N, Matsushita K, et al. Performance of High-Sensitivity Cardiac Troponin Assays To Reflect Comorbidity Burden and Improve Mortality Risk Stratification in Older Adults With Diabetes [published online ahead of print, 2020 Mar 11]. Diabetes Care. 2020;dc192043. doi:10.2337/dc19-2043

https://pubmed.ncbi.nlm.nih.gov/32161049/

[subscribe]

Last Modified: [last-modified] 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

Last Updated on March 26, 2020 by Marie Benz MD FAAD

2,151
Tags:
, , , , , , ,